| IPO Listing At | BSE SME |
| SME IPO Issue Type | Fixed Price Issue |
| Total Issue Size | ₹38.22 Cr |
| Reserved for Market Maker | ₹1.93 Cr |
| Net Issue Size | ₹38.22 Cr |
| Fresh Issue | ₹36.29 Cr |
| Face Value | โน10 Per Equity Share |
| Issue Price | โน98.00 per share |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers | Mefcom Capital Markets Ltd. |
| Allotment Date (Tentative) | 23rd Dec 2025 |
| DRHP | |
| Final Prospectus | |
![]() โน0 A/C OpeningFree MF โน20F&O Trade โน0Delivery 1Cr+Customers Open Free Account โ |
![]() โน0 A/C Openingโน0 AMC Trading Account โน20F&O Trade โน20Delivery FreeIPO Apply Open Free Account โ |
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 2,400 shares ยท Multiples of 1,200 shares
Incorporated in 2002, Phytochem Remedies (India) Limited is a manufacturer of corrugated boxes and corrugated board solutions, catering primarily to industries such as food & beverages, FMCG, pesticides, pharmaceuticals, and automotive, based in Jammu, India.
The company operate in two units at Bari Brahmana, Jammu, with Unit 1 having a total allocated area of 43,360 Sq. Ft. and Unit 2 having an allocated area of 1,73,440 Sq. Ft. Currently, Unit 1 is utilizing approximately 12,000 Sq. Ft. and Unit 2 is utilizing approximately 55,000 Sq. Ft. of total area of respective units.
Products:
As on date September 30, 2025, the company had 51 employees.
Competitive Strengths:
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (โน Cr.) |
|---|---|---|
| 1 | Funding capital expenditure requirements for the purchase of equipment/machineries | 13.60 |
| 2 | Funding capital expenditure requirements towards civil construction | 5.88 |
| 3 | Repayment/pre-payment, in full or in part, of certain borrowings availed by the Company | 9.37 |
| 4 | General Corporate Purposes | 5.64 |
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 53.68 | 44.50 | 41.85 | 37.07 |
| Total Income | 25.01 | 36.81 | 32.90 | 20.83 |
| Profit After Tax | 3.75 | 4.48 | 2.31 | 0.82 |
| EBITDA | 6.72 | 8.69 | 5.88 | 2.91 |
| NET Worth | 16.89 | 13.14 | 8.74 | 6.42 |
| Reserves and Surplus | 9.02 | 9.99 | 5.51 | 3.20 |
| Total Borrowing | 19.32 | 18.69 | 21.02 | 20.30 |
| Amount in ₹ Crore | ||||
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 34.07% |
| ROCE | 25.29% |
| Debt / Equity | 1.42% |
| RoNW | 34.07% |
| PAT Margin | 12.25% |
| EBITDA Margin | 23.78% |
| Price to Book Value | 2.35 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (โน) | 5.68 | 6.38 |
| P/E (x) | 17.24 | 15.37 |
| Promoter Holding | 100.00% | 66.88% |
| Market Cap | โน115.39 Cr. | |
| # | Issue Expenses | Est Amt (โน Cr.) |
|---|---|---|
| 1 | Fees payable to the Lead Manager | 1.72 |
| 2 | Fees Payable to Registrar to the Issue | 0.02 |
| 3 | Fees payable to Legal Advisor | 0.15 |
| 4 | Fees Payable Advertising, Marketing Expenses and Printing Expenses | 0.17 |
| 5 | Fees payable to Regulators including Stock Exchanges and other Intermediaries | 0.11 |
| 6 | Fees payable to Peer Review Auditor | 0.05 |
| 7 | Fees Payable to Market Maker (for Three Years) | 0.09 |
| 8 | Others (Fees payable for marketing & distributing expenses, selling commission, brokerage, processing fees, underwriting fees to underwriters and miscellaneous expenses.) | 1.37 |
| 9 | Escrow/Sponser/Refund Bank Fees | 0.01 |
| 10 | Fees payable to the industry service provider | 0.04 |
| 11 | Fee payable to the independent chartered Engineer | 0.00 |
Last Updated on 23-Dec-2025 09:36:31